What Is Uterine Cancer?

What Is Uterine Cancer?
Everyday Health
Uterine cancer is the most common gynecological cancer in the United States. It forms in the uterus, which is the hollow, pear-shaped organ in the lower abdomen where a fetus develops and grows. Often referred to as endometrial cancer, it most commonly occurs after menopause.

This type of cancer is curable, particularly when it is diagnosed and treated early. Hysterectomy is considered the primary treatment option, but there are other medical treatments used to manage the condition.

Types of Uterine Cancer

There are two main types of uterine cancer. They grow in different types of tissue, and there are many subtypes within those categories.

  • Endometrial Cancer This type of uterine cancer develops in the lining of the uterus, which is also known as the endometrium. Most uterine cancers are endometrial.
  • Uterine Sarcoma This type of uterine cancer originates in the muscle wall of the uterus. It is relatively rare.

Signs and Symptoms of Uterine Cancer

Uterine cancer can cause symptoms in both the early and more advanced stages. Roughly 90 percent of patients diagnosed with uterine cancer report postmenopausal vaginal bleeding, bleeding between periods, or very heavy bleeding during their menstrual cycle.

Other symptoms of uterine cancer include:

  • Abnormal vaginal discharge (even with no traces of blood)
  • Pelvic pain
  • Pain during intercourse
  • Difficulty urinating
  • A mass in the pelvic area
  • Unexpected weight loss

Causes and Risk Factors of Uterine Cancer

While the exact cause of uterine cancer has not been determined, experts have identified certain factors that put people at higher risk.

How Is Uterine Cancer Diagnosed?

Uterine cancer can be detected with several types of examinations.

  • Pelvic Exam During a pelvic exam, your doctor will insert two fingers into the vagina while pressing the other hand down on the abdomen to feel for abnormalities in the uterus and the ovaries. A speculum is inserted into the vagina to visually inspect the area.
  • Transvaginal Ultrasound In this exam, a wandlike device known as a transducer is inserted into the vagina to create an ultrasound video image of the thickness of the uterine lining and determine if there are irregularities.
  • Hysteroscopy During this test, a lighted tube, or hysteroscope, is inserted into the vagina and through the cervix to gain access to and examine the uterus and uterine lining.
  • Endometrial Biopsy Thin suction tubing is used to remove tissue from the uterine lining to be examined and analyzed by a laboratory.
  • Dilation and Curettage If an endometrial biopsy is inconclusive, it may be necessary to do a more extensive procedure called dilation and curettage, or D&C. The cervix is dilated for better access to the uterus and the endometrial lining is scraped to get additional tissue for testing.

Stages of Uterine Cancer

If abnormal cells are detected, the cancer will be classified by one of four stages. All cancers are more curable the earlier they are discovered.

  • Stage 1 The cancer has not spread beyond the uterus.
  • Stage 2 The cancer has spread from the uterus to the cervix.
  • Stage 3 The cancer has spread from the uterus to the vagina, ovaries, and lymph nodes.
  • Stage 4 The cancer has spread to the bladder, rectum, lungs, or bones.

Treatment Options for Uterine Cancer

Uterine cancer is treated by one or a combination of treatments. Ultimately, treatment for uterine cancer depends on the type of cancer and how extensive it is, as well as whether it is localized or has spread (metastasized). Other factors include overall health, age, and personal preferences, such as whether it is important to preserve fertility.

Surgery

A total hysterectomy is the main surgical treatment for uterine cancer. That procedure removes the entire uterus and the cervix. A bilateral salpingo-oophorectomy (removal of the ovaries and fallopian tubes) may also be performed to reduce the risk that the cancer will spread. Your doctor may also remove lymph nodes from the pelvic area to test for any cancer that may have spread outside of the uterus.

Hormone Therapy

Hormone therapy blocks or changes the effects of hormones that contribute to cancer growth. It’s sometimes used in patients who want to preserve the uterus and their fertility. It’s also often used to treat stage 3 or 4 cancer or cancer that has recurred after treatment.

Medication is prescribed to lower the body’s hormone levels so that uterine cancer cells, which grow in response to hormones, might die off. Depending on the drug prescribed, it comes in pill or injection form. Hormone treatment options for endometrial cancer can include:

  • Progestins, which are the primary hormone treatment prescribed
  • Aromatase inhibitors (AIs)
  • Tamoxifen
  • Fulvestrant
  • CDK 4/6 inhibitors

Chemotherapy

Chemotherapy is a type of cancer treatment that uses powerful drugs to kill cancer cells. It’s an effective way to treat cancer, but it also can cause unpleasant side effects such as nausea, fatigue, hair loss, nerve damage, and a loss of appetite. It can be used alone or in combination with other treatments, like surgery and radiation, to improve the patient’s chance for survival.

Drugs that are used to treat uterine cancer include:

  • bevacizumab (Avastin)
  • carboplatin
  • cisplatin
  • docetaxel (Taxotere)
  • doxorubicin (Adriamycin) or liposomal doxorubicin (Doxil)
  • gemcitabine
  • paclitaxel (Taxol)

Radiation Therapy

Radiation therapy is often used after surgery to destroy any remaining cancer cells. This is the main treatment for women whose cancer has returned, and for those who have health conditions that won’t allow them to have surgery. It’s often done along with chemotherapy to eliminate large uterine tumors or cancer that’s spread to other parts of the body.

Your doctor may order CT scans during treatment to ensure that the radiation avoids nearby healthy organs and tissues and to track the shape and size of the tumor. Radiation therapy can be given two ways:

  • Internal radiation therapy, which is when radioactive materials are placed inside the body. It’s also known as brachytherapy.
  • External beam radiation therapy, which is performed with a machine that focuses radiation beams at the tumor.

Targeted Therapy

Targeted drug treatments are designed to attack changes within cancer cells. They are mostly used to treat high-risk endometrial cancers and those that have metastasized. They have different and possibly less severe side effects than chemo drugs, but they are sometimes combined with chemotherapy.

Targeted drugs include:

  • bevacizumab (Avastin) Trastuzamab (Herceptin)
  • cabozantinib (Cabometx)
  • entrectinib (Rozlytrek)
  • everolimus (Afinitor)
  • fam-trastuzumab deruxtecan-nxki (Enhertu)
  • larotrectinib (Vitrakyi)
  • lenvatinib (Lenvima)
  • temsirolimus (Torisel)

Immunotherapy

Immunotherapy uses drugs that help the patient’s own immune system fight the cancer. In the case of uterine cancer, a type of immunotherapy known as a checkpoint inhibitor, specifically a drug called pembrolizumab (Keytruda), may be used. Pembrolizumab is sometimes used in tandem with the targeted therapy lenvatinib (Lenvima).

Prevention of Uterine Cancer

While there is no foolproof way to prevent uterine cancer, certain behaviors can lower your risk factors.

  • Maintain a healthy weight. Women who are overweight are more likely to get endometrial cancer.
  • Exercise regularly. Higher levels of physical activity have been linked to a lower risk of endometrial cancer. Regular exercise can also help you maintain a healthy weight and lower the risk of high blood pressure and diabetes, both of which are risk factors for endometrial cancer.
  • Use hormonal contraceptives. Birth control pills, patches, rings, implants, or an IUD may reduce your endometrial cancer risk.

Lifestyle Changes

When you’re being treated for cancer, living a healthy lifestyle may help improve your day-to-day life and your prognosis. A healthy diet, regular exercise, avoidance of cigarettes and alcohol, and more sleep can help you improve your health and possibly minimize some cancer treatment side effects, such as fatigue, nausea, stress, anxiety, and depression.

Uterine Cancer Prognosis

Every patient with uterine cancer is different, and so are their health outcomes. When diagnosed early, patients with uterine cancer have a very good prognosis.

Those diagnosed before the cancer metastasizes have a five-year survival rate of 95 percent. If the cancer has spread to other areas of the body, the survival rate is 18 percent.

Complications of Uterine Cancer

Cancer of any type is serious, and there can be some significant complications related to both the disease and the treatment, including:

  • Anemia due to blood loss before diagnosis
  • Perforation (hole) of the uterus, which may occur during a dilation and curettage (D&C) or endometrial biopsy
  • Nausea or vomiting from chemotherapy
  • Increased risk of infection from surgery, radiation, and chemotherapy

Research and Statistics

Uterine cancer is the fourth most common cancer for women and the most common gynecological cancer in the United States. In 2025, an estimated 69,120 women will be diagnosed with this type of cancer, and an estimated 13,860 people will die of uterine cancer this year.

Disparities and Inequities in Uterine Cancer

Although uterine cancer rates are slightly higher among white women than Black women, Black women are more likely to die of it. One study found that racial disparities are reflected in higher rates and shorter survival among Black women.

One reason for the shorter survival time is late diagnosis. Approximately 69 percent of white women are diagnosed when the cancer is local compared with 54 percent of Black women. Because Black women are less likely to be diagnosed in the early stage of the disease, their survival rate is lower at every stage.

The Takeaway

  • Uterine cancer, also called endometrial cancer, is the most common gynecological cancer in the United States. It is diagnosed most frequently in postmenopausal women.
  • Early diagnosis and treatment of uterine cancer can lead to a very good prognosis. Surgery is the main treatment option, but others include hormone therapy, chemotherapy, radiation, targeted drugs, and immunotherapy.
  • If you experience postmenopausal bleeding, difficulty urinating, or pelvic pain, seek medical attention right away, as these can be symptoms of uterine cancer.

Common Questions & Answers

What are the risk factors for uterine cancer?
People who are 55 or older are more likely to develop it. Obesity and a high-fat diet also increase risk, as does type 2 diabetes and a prior diagnosis of breast or ovarian cancer.
Bleeding between periods or after menopause; pain during sex or when urinating; pain, pressure, or a lump in the pelvic area; and watery, bloody, or strong smelling discharge are all common symptoms of uterine cancer.
There are currently no screening tests for uterine cancer. A Pap test may discover abnormal uterine cells only if they’ve moved down into the cervix.
Uterine cancer can be detected with a pelvic exam, a transvaginal ultrasound, an endometrial biopsy of the uterine lining, hysteroscopy (when a small telescope is inserted into the uterus), or by scraping endometrial tissue from the uterus.
Most treatments for uterine cancer will make it difficult if not impossible to bear children. Talk to your doctor about fertility preservation options like freezing eggs and embryos if you want to become a parent.

Resources We Trust

walter-tsang-bio

Walter Tsang, MD

Medical Reviewer
Walter Tsang, MD, is a board-certified medical oncologist, hematologist, and lifestyle medicine specialist. Inspired by the ancient Eastern philosophy of yang sheng ("nourishing life"), Dr. Tsang has developed a unique whole-person oncology approach that tailors cancer care and lifestyle recommendations to each patients’ biopsychosocial-spiritual circumstances. He partners with patients on their cancer journeys, emphasizing empowerment, prevention, holistic wellness, quality of life, supportive care, and realistic goals and expectations. This practice model improves clinical outcomes and reduces costs for both patients and the healthcare system. 

Outside of his busy clinical practice, Tsang has taught various courses at UCLA Center for East West Medicine, Loma Linda University, and California University of Science and Medicine. He is passionate about health education and started an online seminar program to teach cancer survivors about nutrition, exercise, stress management, sleep health, and complementary healing methods. Over the years, he has given many presentations on integrative oncology and lifestyle medicine at community events. In addition, he was the founding co-chair of a lifestyle medicine cancer interest group, which promoted integrative medicine education and collaborations among oncology professionals.

Tsang is an active member of American Society of Clinical Oncology, Society for Integrative Oncology, and American College of Lifestyle Medicine. He currently practices at several locations in Southern California. His goal is to transform cancer care in the community, making it more integrative, person-centered, cost-effective and sustainable for the future.
melba-newsome-author-bio

Melba Newsome

Author

Melba Newsome is a veteran freelance journalist with more than 20 years experience reporting on news and general interest topics. She began her career covering what she calls the “freak beat” — writing dramatic narratives about everything from serial-killer groupies to women in harems — for women’s magazines such as Marie Claire, Good Housekeeping, Cosmopolitan, Womans Day, and Redbook.

In the past decade, her reporting has focused primarily on education and health, with a concentration on disparities and rural health. A feature in O, The Oprah Magazine about genetic testing earned her the June Roth Award for Medical Journalism. Melba received a Reynolds Institute fellowship and an EWA Reporting fellowship. Thanks to a Crisis Reporting grant from the Pulitzer Center, she has reported extensively on the physiological, emotional, and societal impact of the novel coronavirus.

Melba grew up in the Arkansas Delta and now lives in Charlotte, North Carolina. When there isn’t a pandemic, she enjoys travel and the arts — she’s seen Hamilton six times and traveled to six of the seven continents.

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Uterine Cancer Statistics. Centers for Disease Control and Prevention. September 9, 2024.
  2. Uterine Cancer (Endometrial Cancer). Cleveland Clinic. March 21, 2023.
  3. Different Types of Uterine Cancer: Risk Factors, Diagnosis, and Treatment. University of Kansas Cancer Center.
  4. Uterine (Endometrial) Cancer Signs & Symptoms. Memorial Sloan Kettering Cancer Center.
  5. Uterine (Endometrial) Cancer Risk Factors & Prevention. Memorial Sloan Kettering Cancer Center.
  6. Tests for Endometrial Cancer. American Cancer Society. February 28, 2025.
  7. Stages of Uterine (Endometrial) Cancer. Memorial Sloan Kettering Cancer Center.
  8. Hysterectomy. Cleveland Clinic. May 31, 2024.
  9. Hormone Therapy for Endometrial Cancer. American Cancer Society. February 28, 2025.
  10. Chemo for Endometrial Cancer. American Cancer Society. February 28, 2025.
  11. Radiation Therapy for Endometrial Cancer. NYU Langone Health Perlmutter Cancer Center.
  12. Radiation for Endometrial Cancer. American Cancer Society. February 28, 2025.
  13. Targeted Therapy for Endometrial Cancer. American Cancer Society. February 28, 2025.
  14. Immunotherapy for Endometrial Cancer. American Cancer Society. February 28, 2025.
  15. Endometrial Cancer Prevention. National Cancer Institute. August 21, 2023.
  16. Lifestyle Changes Women Should Consider to Prevent Cancer. Rogel Cancer Center University of Michigan Health.
  17. Uterine Cancer Outcomes. Emory Winship Cancer Institute.
  18. Endometrial Cancer. MedlinePlus. March 31, 2024.
  19. Key Statistics for Endometrial Cancer. American Cancer Society. February 28, 2025.
  20. Clarke MA et al. Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers. Journal of Clinical Oncology.